| Literature DB >> 30704424 |
Anders Nilsson1, Karolina Sörman2, Josefin Klingvall3, Emma Ovelius3, Jonas Lundberg2,3, Clara Hellner2.
Abstract
BACKGROUND: Depression and anxiety is a major public health problem, in Sweden and internationally. Internet-based interventions are increasingly acknowledged as promising approaches for individuals with varying degrees of mental health problems. We present findings from the implementation of myCompass, a fully automated self-guided intervention of Australian origin, in a Swedish context.Entities:
Keywords: Anxiety; Depression; Internet-based intervention; Stress; myCompass
Mesh:
Year: 2019 PMID: 30704424 PMCID: PMC6357356 DOI: 10.1186/s12888-019-2039-1
Source DB: PubMed Journal: BMC Psychiatry ISSN: 1471-244X Impact factor: 3.630
Fig. 1Flow-chart of participants. The flow-chart shows the flow of participants from initial enrollment to last follow-up survey
Adherence to myCompass
|
|
| Control group | |||
|---|---|---|---|---|---|
| Avg. |
| Avg. |
| ||
| Avg. number of log-ins | 5.7 | 15.8 | 29.9 | 38.2 | – |
| Avg. number of modules commenced | 0.6 | 1.0 | 2.7 | 1.7 | – |
| Avg. number of modules completed | 0.2 | 0.7 | 1.8 | 1.5 | – |
| Number of | 20.0 | 61.0 | 97.6 | 158.8 | – |
| Avg. number of days from registration to last log-in | 15.6 | 43.5 | 84.5 | 96.0 | – |
| Completed first follow-up survey | 19% | 49% | 48% | ||
| Completed second follow-up survey | 13% | 40% | 37% | ||
Note. In the myCompass intervention, modules target mental health problems (e.g., anxiety, sleep disturbances, depression and stress)
aActive users are defined as participants filling out > 5 self-monitor questionnaires and commencing at least one module
Fig. 2Number of log-ins to myCompass. Displays the number of participants who logged in to myCompass, and how frequently
Repeated measures ANOVA for three subgroups, only including completersa
| Control group ( |
|
| |||||||
|---|---|---|---|---|---|---|---|---|---|
| Score | 95% CI | Diff. from ctrl | 95% CI | p-value | Diff from ctrl | 95% CI | |||
| PHQ-9 | |||||||||
| Pre-treatment | 10.36 | [9.58, 11.15] | – | 0.71 | [−1.12, 2.54] | 0.447 | 1.42 | [−1.61, 4.45] | .359 |
| Post-t change | −3.11 | [−3.86, − 2.37] | .000* | 0.11 | [− 1.36, 1.86] | 0.900 | 0.11 | [−2.77, 2.99] | .939 |
| 19 week change | −3.51 | [−4.26, − 2.77] | .000* | −0.02 | [−1.77, 1.73] | 0.979 | −1.93 | [−4.81, − 0.95] | .188 |
| GAD-7 | |||||||||
| Pre-treatment | 8.88 | [8.24, 9.54] | – | 0.08 | [−1.45, 1.60] | 0.922 | −0.11 | [−2.63, 2.41] | .932 |
| Post-t change | −2.34 | [−3.04, −1.65] | .000* | 0.49 | [−1.14, 2.11] | 0.556 | 0.90 | [−1.79, 3.58] | .511 |
| 19 week change | −2.36 | [−3.06, −1.66] | .000* | 1.00 | [−0.62, 2.63] | 0.226 | 0.58 | [−2.10, −3.27] | .670 |
Note. PHQ-9 The Patient Health Questionnaire-9. GAD-7 The Generalized Anxiety Disorder 7-item scale
aCompleters were defined as participants who completed all three surveys (at baseline and follow-ups)
*indicates a significant result at the 0.05 level
Mixed models all users
| ( | Score | 95% CI | N | |
|---|---|---|---|---|
| PHQ-9 | ||||
| Pre-treatment | 10.37 | [9.96, 10.78] | – | – |
| Post-t change | −2.53 | [−3.00, − 2.06] | .000* | – |
| 19 week change | − 2.97 | [− 3.50, − 2.44] | .000* | – |
| Control | 0.00 | – | – | 419 |
|
| 0.27 | [−0.30, 0.83] | .353 | 418 |
| GAD-7 | ||||
| Pre-treatment | 9.05 | [8.73, 9.39] | – | – |
| Post-t change | −2.03 | [−2.45, −1.62] | .000* | – |
| 19 week change | −2.10 | [−2.56, − 1.63] | .000* | – |
| Control | 0.00 | – | – | 419 |
|
| 0.24 | [−0.20, 0.67] | .280 | 418 |
Note. PHQ-9 The Patient Health Questionnaire-9. GAD-7 The Generalized Anxiety Disorder 7-item scale
Mixed models comparing controls, myCompass all users and my Compass active users
| ( | Score | 95% CI | N | |
|---|---|---|---|---|
| PHQ-9 | ||||
| Pre-treatment | 10.37 | [9.96, 10.78] | – | – |
| Post-t change | −2.54 | [−3.01, − 2.07] | .000* | – |
| 19 week change | −2.98 | [− 3.51, − 2.45] | .000* | – |
| Control | 0.00 | 419 | ||
|
| 0.22 | [−0.36, − 0.80] | .449 | 383 |
| Active users | 0.65 | [−0.71, −2.01] | .350 | 35 |
| GAD-7 | ||||
| Pre-treatment | 9.05 | [8.73, 9.37] | – | – |
| Post-t change | −2.04 | [−2.45, −1.62] | .000* | – |
| 19 week change | −2.10 | [−2.56, − 1.63] | .000* | – |
| Control | 0.00 | – | – | 419 |
|
| 0.24 | [−0.21, 0.69] | .300 | 383 |
| Active users | 0.26 | [−0.78, 1.30] | .625 | 35 |
Note. PHQ-9 The Patient Health Questionnaire-9. GAD-7 The Generalized Anxiety Disorder 7-item scale
Descriptive information for the subgroup of participants registered post May 2016, divided into MyCompass and controls
|
| Controls | |
|---|---|---|
| Gender | ||
| Female | 49 (63%) | 52 (66%) |
| Male | 27 (35%) | 23 (29%) |
| Other/blank | 2 (3%) | 4 (5%) |
| Employmenta | ||
| Employed more than 50% | 43 (55%) | 55 (70%) |
| Employed less than 50% | 14 (18%) | 10 (13%) |
| Retired | 21 (27%) | 14 (18%) |
| Education | ||
| No formal education | 7 (9%) | 2 (3%) |
| Elementary school | 5 (6%) | 0 (0%) |
| Secondary school | 10 (13%) | 22 (28%) |
| Post-secondary education (e.g. university education) | 49 (63%) | 54 (68%) |
Note. aEmployment includes any participation in the labor force such as working or studying